1. Home
  2. EXPO vs TNGX Comparison

EXPO vs TNGX Comparison

Compare EXPO & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$66.56

Market Cap

3.4B

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$21.57

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
TNGX
Founded
1967
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EXPO
TNGX
Price
$66.56
$21.57
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$88.00
$20.00
AVG Volume (30 Days)
425.4K
3.7M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
1.86%
N/A
EPS Growth
N/A
26.89
EPS
2.07
N/A
Revenue
$582,014,000.00
$62,384,000.00
Revenue This Year
$12.75
N/A
Revenue Next Year
$8.50
N/A
P/E Ratio
$32.11
N/A
Revenue Growth
4.21
48.29
52 Week Low
$63.25
$1.04
52 Week High
$83.92
$22.20

Technical Indicators

Market Signals
Indicator
EXPO
TNGX
Relative Strength Index (RSI) 45.42 74.32
Support Level $64.55 $5.98
Resistance Level $73.91 $21.82
Average True Range (ATR) 2.17 1.24
MACD 0.11 0.08
Stochastic Oscillator 54.67 90.10

Price Performance

Historical Comparison
EXPO
TNGX

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: